...competing γδ T cell therapy has already entered the clinic: TC Biopharm Ltd.’s allogeneic, unmodified blood-derived TCB002. TC Biopharm...
...Tokyo, Japan Scotia Biologics Ltd., Aberdeen, U.K. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), Tokyo, Japan TC Biopharm Ltd....

...Ltd. CMD-502 CAR-NKT cells with MHC I and II peptides down-regulated by shRNA shRNA Preclinical TC Biopharm Ltd....

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Cancer Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...

...partnered with at least five other companies in oncology R&D deals: γδ T cell company TC BioPharm Ltd....
...NASDAQ:GILD) and Five Prime Therapeutics Inc. (NASDAQ:FPRX). Three of the deals -- those with Celgene, TC BioPharm...
...$632.5 million follow-on. Regeneron dipped $4.83 to $390.05. Allison Johnson Adicet Bio Inc. bluebird bio Inc. Medigene AG Regeneron Pharmaceuticals Inc. TC Biopharm Ltd. Celgene...

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....

...also known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); TC BioPharm Ltd....

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....

...known as Lymphact (Evora, Portugal); Immatics Biotechnologies GmbH (Tuebingen, Germany); Incysus Ltd. (Hamilton, Bermuda); and TC BioPharm Ltd....

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...Dec. 8, 2017) . Scotia Biologics, Aberdeen, U.K. TC BioPharm Ltd., Edinburg, U.K. Business: Cancer Sandi Wong Scotia Biologics Ltd. TC Biopharm Ltd....

...deal. TC BioPharm will use its ImmuniCAR platform to develop the antibodies into CAR T-based immunotherapies. TC BioPharm's...
...and is eligible for milestones and royalties. Moussavi declined to disclose financial terms. In December, TC BioPharm...
...hematologic malignancies and solid tumors using ImmuniCAR technology (see BioCentury Extra, Dec. 7, 2017) . Sandi Wong TC Biopharm Ltd. Epidermal...